176 related articles for article (PubMed ID: 32021192)
1. Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment.
Guo D; Xu P; Chen D; Wang L; Zhu Y; Zuo Y; Chen B
Int J Nanomedicine; 2020; 15():521-536. PubMed ID: 32021192
[TBL] [Abstract][Full Text] [Related]
2. Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo.
Zhou Y; Wang R; Chen B; Sun D; Hu Y; Xu P
Int J Nanomedicine; 2016; 11():5429-5442. PubMed ID: 27799767
[TBL] [Abstract][Full Text] [Related]
3. A novel immunoliposome mediated by CD123 antibody targeting to acute myeloid leukemia cells.
Wang Y; Liu F; Wang Q; Xiang H; Jin H; Li H; Mao S
Int J Pharm; 2017 Aug; 529(1-2):531-542. PubMed ID: 28583331
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia.
Liu FR; Jin H; Wang Y; Chen C; Li M; Mao SJ; Wang Q; Li H
Drug Deliv; 2017 Nov; 24(1):882-890. PubMed ID: 28574300
[TBL] [Abstract][Full Text] [Related]
5. CD123/CD33 dual-antibody modified liposomes effectively target acute myeloid leukemia cells and reduce antigen-negative escape.
Sun S; Zou H; Li L; Liu Q; Ding N; Zeng L; Li H; Mao S
Int J Pharm; 2019 Sep; 568():118518. PubMed ID: 31319147
[TBL] [Abstract][Full Text] [Related]
6. PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.
Bao W; Liu R; Wang Y; Wang F; Xia G; Zhang H; Li X; Yin H; Chen B
Int J Nanomedicine; 2015; 10():557-66. PubMed ID: 25609961
[TBL] [Abstract][Full Text] [Related]
7. CdTe quantum dots with daunorubicin induce apoptosis of multidrug-resistant human hepatoma HepG2/ADM cells: in vitro and in vivo evaluation.
Zhang G; Shi L; Selke M; Wang X
Nanoscale Res Lett; 2011 Jun; 6(1):418. PubMed ID: 21711951
[TBL] [Abstract][Full Text] [Related]
8. Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation.
Bao W; Liu R; Xia G; Wang F; Chen B
Drug Des Devel Ther; 2019; 13():1107-1115. PubMed ID: 31040647
[TBL] [Abstract][Full Text] [Related]
9. Imaging and inhibition of multi-drug resistance in cancer cells via specific association with negatively charged CdTe quantum dots.
Zhou Y; Shi L; Li Q; Jiang H; Lv G; Zhao J; Wu C; Selke M; Wang X
Biomaterials; 2010 Jun; 31(18):4958-63. PubMed ID: 20303165
[TBL] [Abstract][Full Text] [Related]
10. Daunorubicin-TiO2 nanocomposites as a "smart" pH-responsive drug delivery system.
Zhang H; Wang C; Chen B; Wang X
Int J Nanomedicine; 2012; 7():235-42. PubMed ID: 22275838
[TBL] [Abstract][Full Text] [Related]
11. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
[TBL] [Abstract][Full Text] [Related]
12. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model].
Lu J; Jin J; Xu WL
Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):228-33. PubMed ID: 16624066
[TBL] [Abstract][Full Text] [Related]
13. Cancer Cell Targeting Using Folic Acid/Anti-HER2 Antibody Conjugated Fluorescent CdSe/CdS/ZnS-Mercaptopropionic Acid and CdTe-Mercaptosuccinic Acid Quantum Dots.
Singh G; Kumar M; Soni U; Arora V; Bansal V; Gupta D; Bhat M; Dinda AK; Sapra S; Singh H
J Nanosci Nanotechnol; 2016 Jan; 16(1):130-43. PubMed ID: 27398438
[TBL] [Abstract][Full Text] [Related]
14. Increased CD34+CD38 -CD123 + cells in myelodysplastic syndrome displaying malignant features similar to those in AML.
Li LJ; Tao JL; Fu R; Wang HQ; Jiang HJ; Yue LZ; Zhang W; Liu H; Shao ZH
Int J Hematol; 2014 Jul; 100(1):60-9. PubMed ID: 24846193
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity of acute myeloid leukemia cells to daunorubicin depends on P2X7A versus P2X7B receptor expression.
Pegoraro A; Orioli E; De Marchi E; Salvestrini V; Milani A; Di Virgilio F; Curti A; Adinolfi E
Cell Death Dis; 2020 Oct; 11(10):876. PubMed ID: 33071281
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
Wang J; Chen B; Cheng J; Cai X; Xia G; Liu R; Wang X
Int J Nanomedicine; 2011; 6():1027-34. PubMed ID: 21720514
[TBL] [Abstract][Full Text] [Related]
17. Daunorubicin-loaded magnetic nanoparticles of Fe(3)O(4) greatly enhance the responses of multidrug-resistant K562 leukemic cells in a nude mouse xenograft model to chemotherapy.
Lai BB; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):345-51. PubMed ID: 19379564
[TBL] [Abstract][Full Text] [Related]
18. CD123 CAR T cells for the treatment of myelodysplastic syndrome.
Stevens BM; Zhang W; Pollyea DA; Winters A; Gutman J; Smith C; Budde E; Forman SJ; Jordan CT; Purev E
Exp Hematol; 2019 Jun; 74():52-63.e3. PubMed ID: 31136781
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice.
Lee EM; Yee D; Busfield SJ; McManus JF; Cummings N; Vairo G; Wei A; Ramshaw HS; Powell JA; Lopez AF; Lewis ID; McCall MN; Lock RB
Haematologica; 2015 Jul; 100(7):914-26. PubMed ID: 26130514
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of multi-functional liposomes containing daunorubicin and emetine for treatment of acute myeloid leukaemia.
Myhren L; Nilssen IM; Nicolas V; Døskeland SO; Barratt G; Herfindal L
Eur J Pharm Biopharm; 2014 Sep; 88(1):186-93. PubMed ID: 24747809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
